

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.47235941 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.47235941 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.20440626 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.20440626 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.44011692 |
| 6 | glyoxylate metabolic process (GO:0046487) | 4.96255030 |
| 7 | regulation of hexokinase activity (GO:1903299) | 4.88400547 |
| 8 | regulation of glucokinase activity (GO:0033131) | 4.88400547 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.76917168 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.67115155 |
| 11 | signal peptide processing (GO:0006465) | 4.58131750 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.56284252 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.51996307 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.51996307 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.51996307 |
| 16 | fatty acid elongation (GO:0030497) | 4.50609936 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.33224505 |
| 18 | aldehyde catabolic process (GO:0046185) | 4.32299583 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.31409758 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 4.30688598 |
| 21 | cysteine metabolic process (GO:0006534) | 4.23783857 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.20312943 |
| 23 | bile acid metabolic process (GO:0008206) | 4.14460535 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 4.08687716 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.02082400 |
| 26 | coenzyme catabolic process (GO:0009109) | 4.01067507 |
| 27 | tyrosine metabolic process (GO:0006570) | 3.99731087 |
| 28 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.87950309 |
| 29 | acylglycerol homeostasis (GO:0055090) | 3.86624597 |
| 30 | triglyceride homeostasis (GO:0070328) | 3.86624597 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85580626 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 3.82004071 |
| 33 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81344163 |
| 34 | regulation of fibrinolysis (GO:0051917) | 3.75761417 |
| 35 | cellular glucuronidation (GO:0052695) | 3.74972886 |
| 36 | acetyl-CoA metabolic process (GO:0006084) | 3.74896985 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 3.74393941 |
| 38 | positive regulation of glycolytic process (GO:0045821) | 3.74038837 |
| 39 | ketone body metabolic process (GO:1902224) | 3.73008333 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 3.72515408 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.71875772 |
| 42 | protein carboxylation (GO:0018214) | 3.71875772 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 3.71448189 |
| 44 | very long-chain fatty acid metabolic process (GO:0000038) | 3.70750694 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 3.68019197 |
| 46 | cofactor catabolic process (GO:0051187) | 3.67000746 |
| 47 | short-chain fatty acid metabolic process (GO:0046459) | 3.65379662 |
| 48 | heme transport (GO:0015886) | 3.64628500 |
| 49 | lysine metabolic process (GO:0006553) | 3.62041900 |
| 50 | lysine catabolic process (GO:0006554) | 3.62041900 |
| 51 | regulation of protein activation cascade (GO:2000257) | 3.59522051 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 3.59251322 |
| 53 | glucuronate metabolic process (GO:0019585) | 3.58813155 |
| 54 | uronic acid metabolic process (GO:0006063) | 3.58813155 |
| 55 | cholesterol efflux (GO:0033344) | 3.57937664 |
| 56 | urea metabolic process (GO:0019627) | 3.55159663 |
| 57 | urea cycle (GO:0000050) | 3.55159663 |
| 58 | respiratory chain complex IV assembly (GO:0008535) | 3.54917728 |
| 59 | inositol phosphate catabolic process (GO:0071545) | 3.53573667 |
| 60 | cholesterol biosynthetic process (GO:0006695) | 3.51246621 |
| 61 | fatty acid beta-oxidation (GO:0006635) | 3.49794453 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.49140781 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.48446548 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.48446548 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.48446548 |
| 66 | complement activation, alternative pathway (GO:0006957) | 3.47587715 |
| 67 | amine catabolic process (GO:0009310) | 3.47556664 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 3.47556664 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 3.45863795 |
| 70 | fatty acid catabolic process (GO:0009062) | 3.45789282 |
| 71 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.44280316 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.41339429 |
| 73 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41010532 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.40296853 |
| 75 | thioester metabolic process (GO:0035383) | 3.39307130 |
| 76 | acyl-CoA metabolic process (GO:0006637) | 3.39307130 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.38412281 |
| 78 | organic acid catabolic process (GO:0016054) | 3.38412281 |
| 79 | monocarboxylic acid catabolic process (GO:0072329) | 3.38310618 |
| 80 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.37425080 |
| 81 | fatty acid oxidation (GO:0019395) | 3.35928864 |
| 82 | lactate metabolic process (GO:0006089) | 3.35333525 |
| 83 | regulation of complement activation (GO:0030449) | 3.34210717 |
| 84 | ethanol oxidation (GO:0006069) | 3.33503856 |
| 85 | acyl-CoA biosynthetic process (GO:0071616) | 3.33316686 |
| 86 | thioester biosynthetic process (GO:0035384) | 3.33316686 |
| 87 | lipid oxidation (GO:0034440) | 3.30787767 |
| 88 | aspartate family amino acid catabolic process (GO:0009068) | 3.30083612 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.28390298 |
| 90 | endocrine pancreas development (GO:0031018) | 3.28368480 |
| 91 | ATP synthesis coupled proton transport (GO:0015986) | 3.28108330 |
| 92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.28108330 |
| 93 | branched-chain amino acid catabolic process (GO:0009083) | 3.27529769 |
| 94 | homocysteine metabolic process (GO:0050667) | 3.26929341 |
| 95 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.26749156 |
| 96 | bile acid and bile salt transport (GO:0015721) | 3.24631492 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 3.24231154 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.23663247 |
| 99 | glutamate metabolic process (GO:0006536) | 3.22444621 |
| 100 | serine family amino acid metabolic process (GO:0009069) | 3.21245995 |
| 101 | phospholipid efflux (GO:0033700) | 3.20939359 |
| 102 | alkaloid metabolic process (GO:0009820) | 3.20444489 |
| 103 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.19944800 |
| 104 | proline metabolic process (GO:0006560) | 3.18511426 |
| 105 | drug catabolic process (GO:0042737) | 3.18188287 |
| 106 | polyol catabolic process (GO:0046174) | 3.17515601 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.15856544 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15856544 |
| 109 | macroautophagy (GO:0016236) | 3.13371914 |
| 110 | opsonization (GO:0008228) | 3.13024531 |
| 111 | serine family amino acid biosynthetic process (GO:0009070) | 3.12390275 |
| 112 | inositol phosphate dephosphorylation (GO:0046855) | 3.12334112 |
| 113 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.12334112 |
| 114 | respiratory electron transport chain (GO:0022904) | 3.11829461 |
| 115 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.08226801 |
| 116 | cytochrome complex assembly (GO:0017004) | 3.07772705 |
| 117 | glycerophospholipid catabolic process (GO:0046475) | 3.01475455 |
| 118 | exogenous drug catabolic process (GO:0042738) | 2.98168867 |
| 119 | insulin secretion (GO:0030073) | 2.87762576 |
| 120 | positive regulation of protein autophosphorylation (GO:0031954) | 2.87419689 |
| 121 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.87037054 |
| 122 | S-adenosylmethionine metabolic process (GO:0046500) | 2.86119211 |
| 123 | regulation of protein glycosylation (GO:0060049) | 2.85067457 |
| 124 | establishment of protein localization to Golgi (GO:0072600) | 2.82190152 |
| 125 | oxidative demethylation (GO:0070989) | 2.82037877 |
| 126 | xenobiotic catabolic process (GO:0042178) | 2.81286965 |
| 127 | positive regulation of insulin secretion (GO:0032024) | 2.79771017 |
| 128 | righting reflex (GO:0060013) | 2.79456259 |
| 129 | positive regulation of peptide hormone secretion (GO:0090277) | 2.77883591 |
| 130 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.76365161 |
| 131 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.75641075 |
| 132 | peptide hormone processing (GO:0016486) | 2.74093350 |
| 133 | reflex (GO:0060004) | 2.72681740 |
| 134 | response to pheromone (GO:0019236) | 2.66436781 |
| 135 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.66148409 |
| 136 | positive regulation of peptide secretion (GO:0002793) | 2.65653863 |
| 137 | zinc ion transport (GO:0006829) | 2.65375496 |
| 138 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.64851960 |
| 139 | epoxygenase P450 pathway (GO:0019373) | 2.64092757 |
| 140 | detection of calcium ion (GO:0005513) | 2.56452132 |
| 141 | protein K11-linked deubiquitination (GO:0035871) | 2.55768102 |
| 142 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.54337727 |
| 143 | protein targeting to Golgi (GO:0000042) | 2.53226645 |
| 144 | nucleotide transmembrane transport (GO:1901679) | 2.49705491 |
| 145 | protein prenylation (GO:0018342) | 2.49575695 |
| 146 | prenylation (GO:0097354) | 2.49575695 |
| 147 | dopamine transport (GO:0015872) | 2.49541937 |
| 148 | nitric oxide mediated signal transduction (GO:0007263) | 2.48910402 |
| 149 | flavonoid metabolic process (GO:0009812) | 2.48061473 |
| 150 | auditory receptor cell differentiation (GO:0042491) | 2.42742521 |
| 151 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.40670810 |
| 152 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.40051926 |
| 153 | regulation of energy homeostasis (GO:2000505) | 2.39934244 |
| 154 | proline transport (GO:0015824) | 2.39460788 |
| 155 | omega-hydroxylase P450 pathway (GO:0097267) | 2.39425702 |
| 156 | positive regulation of meiosis (GO:0045836) | 2.39340166 |
| 157 | phenylpropanoid metabolic process (GO:0009698) | 2.38210737 |
| 158 | lipid particle organization (GO:0034389) | 2.37802734 |
| 159 | regulation of acrosome reaction (GO:0060046) | 2.36426570 |
| 160 | protein localization to Golgi apparatus (GO:0034067) | 2.35581485 |
| 161 | retinol metabolic process (GO:0042572) | 2.35311826 |
| 162 | negative regulation of protein activation cascade (GO:2000258) | 2.34400221 |
| 163 | organic cation transport (GO:0015695) | 2.34207793 |
| 164 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.33946958 |
| 165 | mannosylation (GO:0097502) | 2.33819019 |
| 166 | protein complex biogenesis (GO:0070271) | 2.33051107 |
| 167 | negative regulation of hormone metabolic process (GO:0032351) | 2.33030083 |
| 168 | fatty acid homeostasis (GO:0055089) | 2.32489026 |
| 169 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.30483057 |
| 170 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.30008799 |
| 171 | negative regulation of complement activation (GO:0045916) | 2.29814263 |
| 172 | fatty acid transmembrane transport (GO:1902001) | 2.29027682 |
| 173 | negative regulation of protein oligomerization (GO:0032460) | 2.28432565 |
| 174 | adaptation of signaling pathway (GO:0023058) | 2.28024459 |
| 175 | protein localization to cilium (GO:0061512) | 2.27752493 |
| 176 | phospholipid homeostasis (GO:0055091) | 2.27256425 |
| 177 | thyroid hormone metabolic process (GO:0042403) | 2.26171292 |
| 178 | L-fucose metabolic process (GO:0042354) | 2.25444532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.36349150 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.01155483 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.08116240 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.97673871 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.55116884 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.25604084 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.21510629 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.93800644 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.76690656 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.41310022 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.34143711 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66006019 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.44413479 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.32630368 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.20644249 |
| 16 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.15072159 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.10100662 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98327159 |
| 19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.96311919 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.94384514 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.92153756 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.91025105 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90793257 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.87836792 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87049591 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.86273964 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.84509430 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82768490 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.81846227 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.80601517 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79268417 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70253267 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67664916 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65174134 |
| 35 | STAT3_23295773_ChIP-Seq_U87_Human | 1.63035173 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.60359637 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60355866 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.56932321 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.55744604 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.53069193 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50100085 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49895368 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49146439 |
| 44 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.48980351 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48252887 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48252887 |
| 47 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47630554 |
| 48 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47554019 |
| 49 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.47035776 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46851064 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45638673 |
| 52 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.45593692 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43402022 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43254203 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42161751 |
| 56 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41965450 |
| 57 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.41418507 |
| 58 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.36804728 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35003129 |
| 60 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34474208 |
| 61 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31087823 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.29125897 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28142790 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25581381 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24868806 |
| 66 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22802316 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22359955 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22073917 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20955832 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20718808 |
| 71 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19892936 |
| 72 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19737023 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18692618 |
| 74 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.18348936 |
| 75 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17640772 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17578787 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17441190 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16768346 |
| 79 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15561658 |
| 80 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13190839 |
| 81 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13016253 |
| 82 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.12181811 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12041406 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12041406 |
| 85 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09920640 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09577644 |
| 87 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08969350 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08640413 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08014919 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07983307 |
| 91 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07002648 |
| 92 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.06482441 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06427408 |
| 94 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06238489 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.02861663 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02648929 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02404742 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01737191 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01679656 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01620145 |
| 101 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01390992 |
| 102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01305616 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00640736 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00640736 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00183219 |
| 106 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.99861874 |
| 107 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99801832 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96737942 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90151712 |
| 110 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.87929941 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86514975 |
| 112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85389498 |
| 113 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84683594 |
| 114 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83429264 |
| 115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82708758 |
| 116 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82142568 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82070857 |
| 118 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82003413 |
| 119 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.81455338 |
| 120 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81384340 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81073904 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80370141 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80343952 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78716336 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77405755 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75425203 |
| 127 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.75094391 |
| 128 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.74019499 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.72731421 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72578422 |
| 131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72578422 |
| 132 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.72363363 |
| 133 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.71965999 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 0.70666898 |
| 135 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70495088 |
| 136 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69688154 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67691471 |
| 138 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.67425424 |
| 139 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.65962993 |
| 140 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.65940988 |
| 141 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.64074876 |
| 142 | GATA1_22025678_ChIP-Seq_K562_Human | 0.64019421 |
| 143 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.63709041 |
| 144 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.63628748 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63327911 |
| 146 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.63190267 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63157512 |
| 148 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.63137353 |
| 149 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.63093211 |
| 150 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63034625 |
| 151 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62813693 |
| 152 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62404703 |
| 153 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.62108015 |
| 154 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.60862856 |
| 155 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60605706 |
| 156 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.60369735 |
| 157 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.60301750 |
| 158 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60198248 |
| 159 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.59948100 |
| 160 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.59925040 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59704646 |
| 162 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.58015391 |
| 163 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.57796602 |
| 164 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.55976949 |
| 165 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.55574590 |
| 166 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.55314878 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54659086 |
| 168 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.54446445 |
| 169 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.53013868 |
| 170 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.53002436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.17560816 |
| 2 | MP0005360_urolithiasis | 5.91732685 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.54556005 |
| 4 | MP0005365_abnormal_bile_salt | 5.15123322 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.74888635 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.65189815 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.33747957 |
| 8 | MP0003195_calcinosis | 3.25232828 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.73573890 |
| 10 | MP0005332_abnormal_amino_acid | 2.70458943 |
| 11 | MP0003252_abnormal_bile_duct | 2.68401766 |
| 12 | MP0009840_abnormal_foam_cell | 2.63248849 |
| 13 | MP0005083_abnormal_biliary_tract | 2.55560924 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.42099329 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.24029623 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.03908765 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.00066166 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.99939839 |
| 19 | MP0005451_abnormal_body_composition | 1.99869511 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.95335955 |
| 21 | MP0002102_abnormal_ear_morphology | 1.95263017 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.91043165 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.88385733 |
| 24 | MP0009046_muscle_twitch | 1.82020549 |
| 25 | MP0009697_abnormal_copulation | 1.81481294 |
| 26 | MP0003787_abnormal_imprinting | 1.77447653 |
| 27 | MP0001944_abnormal_pancreas_morphology | 1.76949099 |
| 28 | MP0000427_abnormal_hair_cycle | 1.75017968 |
| 29 | MP0002693_abnormal_pancreas_physiology | 1.71455427 |
| 30 | MP0001764_abnormal_homeostasis | 1.70514663 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.68354850 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.66936221 |
| 33 | MP0002163_abnormal_gland_morphology | 1.65337648 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.64513269 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.61227429 |
| 36 | MP0000609_abnormal_liver_physiology | 1.59665008 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.59249012 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.55495140 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.54953503 |
| 40 | MP0005253_abnormal_eye_physiology | 1.54110434 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.53126198 |
| 42 | MP0003186_abnormal_redox_activity | 1.51822615 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51363236 |
| 44 | MP0004043_abnormal_pH_regulation | 1.51051203 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.48319282 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.46734460 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.44750061 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.43669190 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.42982684 |
| 50 | MP0003011_delayed_dark_adaptation | 1.42746078 |
| 51 | MP0003283_abnormal_digestive_organ | 1.40876547 |
| 52 | MP0002254_reproductive_system_inflammat | 1.40087523 |
| 53 | MP0003646_muscle_fatigue | 1.39144285 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.37435552 |
| 55 | MP0002090_abnormal_vision | 1.37124974 |
| 56 | MP0001756_abnormal_urination | 1.36653057 |
| 57 | MP0000749_muscle_degeneration | 1.33882518 |
| 58 | MP0003868_abnormal_feces_composition | 1.31334881 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.26708292 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.26359580 |
| 61 | MP0004270_analgesia | 1.21854007 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.21780351 |
| 63 | MP0003329_amyloid_beta_deposits | 1.20506151 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.18281953 |
| 65 | MP0004924_abnormal_behavior | 1.18281953 |
| 66 | MP0005266_abnormal_metabolism | 1.15938016 |
| 67 | MP0001661_extended_life_span | 1.15728200 |
| 68 | MP0001529_abnormal_vocalization | 1.12686747 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.12398785 |
| 70 | MP0002938_white_spotting | 1.12185806 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.11608792 |
| 72 | MP0000516_abnormal_urinary_system | 1.11089048 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 1.11089048 |
| 74 | MP0008872_abnormal_physiological_respon | 1.10617285 |
| 75 | MP0004142_abnormal_muscle_tone | 1.08884297 |
| 76 | MP0002269_muscular_atrophy | 1.08278505 |
| 77 | MP0009745_abnormal_behavioral_response | 1.08024087 |
| 78 | MP0004130_abnormal_muscle_cell | 1.07941235 |
| 79 | MP0003718_maternal_effect | 1.07713656 |
| 80 | MP0008775_abnormal_heart_ventricle | 1.03378484 |
| 81 | MP0001485_abnormal_pinna_reflex | 1.03221207 |
| 82 | MP0000604_amyloidosis | 1.03134671 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 1.02483480 |
| 84 | MP0000747_muscle_weakness | 1.02054168 |
| 85 | MP0004036_abnormal_muscle_relaxation | 1.00675344 |
| 86 | MP0002822_catalepsy | 0.99566658 |
| 87 | MP0010678_abnormal_skin_adnexa | 0.98802902 |
| 88 | MP0002272_abnormal_nervous_system | 0.96457182 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.96196188 |
| 90 | MP0002928_abnormal_bile_duct | 0.94371697 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.90933906 |
| 92 | MP0004085_abnormal_heartbeat | 0.90489368 |
| 93 | MP0005535_abnormal_body_temperature | 0.88853267 |
| 94 | MP0000920_abnormal_myelination | 0.88775938 |
| 95 | MP0001905_abnormal_dopamine_level | 0.88444921 |
| 96 | MP0002971_abnormal_brown_adipose | 0.88225045 |
| 97 | MP0004484_altered_response_of | 0.88020782 |
| 98 | MP0002064_seizures | 0.86981591 |
| 99 | MP0001486_abnormal_startle_reflex | 0.86365205 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.85053516 |
| 101 | MP0003633_abnormal_nervous_system | 0.85030804 |
| 102 | MP0003045_fibrosis | 0.84751653 |
| 103 | MP0002168_other_aberrant_phenotype | 0.84532058 |
| 104 | MP0003690_abnormal_glial_cell | 0.84467172 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.84198706 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.83982958 |
| 107 | MP0005408_hypopigmentation | 0.82260253 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.80784187 |
| 109 | MP0000566_synostosis | 0.79405705 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.78883511 |
| 111 | MP0002557_abnormal_social/conspecific_i | 0.77347195 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.77345042 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.76438662 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.76031863 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.75007426 |
| 116 | MP0005330_cardiomyopathy | 0.74708045 |
| 117 | MP0005647_abnormal_sex_gland | 0.72648385 |
| 118 | MP0000751_myopathy | 0.72154321 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.72137233 |
| 120 | MP0005171_absent_coat_pigmentation | 0.71213399 |
| 121 | MP0004147_increased_porphyrin_level | 0.69480236 |
| 122 | MP0002106_abnormal_muscle_physiology | 0.68981031 |
| 123 | MP0001984_abnormal_olfaction | 0.68022924 |
| 124 | MP0000598_abnormal_liver_morphology | 0.68009544 |
| 125 | MP0005334_abnormal_fat_pad | 0.67274309 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.65254276 |
| 127 | MP0002796_impaired_skin_barrier | 0.65140748 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.61229432 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.60411794 |
| 130 | MP0005369_muscle_phenotype | 0.59718920 |
| 131 | MP0000579_abnormal_nail_morphology | 0.58669680 |
| 132 | MP0005448_abnormal_energy_balance | 0.58426859 |
| 133 | MP0005395_other_phenotype | 0.57869762 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.56785830 |
| 135 | MP0004233_abnormal_muscle_weight | 0.56729577 |
| 136 | MP0008469_abnormal_protein_level | 0.55067341 |
| 137 | MP0004381_abnormal_hair_follicle | 0.54066804 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.53249492 |
| 139 | MP0000462_abnormal_digestive_system | 0.52061908 |
| 140 | MP0009763_increased_sensitivity_to | 0.50583304 |
| 141 | MP0003953_abnormal_hormone_level | 0.50429373 |
| 142 | MP0006082_CNS_inflammation | 0.48928644 |
| 143 | MP0002295_abnormal_pulmonary_circulatio | 0.48328426 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.47688895 |
| 145 | MP0009764_decreased_sensitivity_to | 0.47099247 |
| 146 | MP0006072_abnormal_retinal_apoptosis | 0.46157732 |
| 147 | MP0002229_neurodegeneration | 0.45594472 |
| 148 | MP0003950_abnormal_plasma_membrane | 0.44321534 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.44313920 |
| 150 | MP0000538_abnormal_urinary_bladder | 0.41591149 |
| 151 | MP0004185_abnormal_adipocyte_glucose | 0.40805498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77582547 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.17880125 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.43388430 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.25339633 |
| 5 | * Hypobetalipoproteinemia (HP:0003563) | 4.22806729 |
| 6 | Xanthomatosis (HP:0000991) | 4.17787726 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.03236454 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 3.77305530 |
| 9 | Hypothermia (HP:0002045) | 3.76244166 |
| 10 | Hyperglycinemia (HP:0002154) | 3.74902667 |
| 11 | Acute encephalopathy (HP:0006846) | 3.72859093 |
| 12 | Ketosis (HP:0001946) | 3.71634048 |
| 13 | Cerebral edema (HP:0002181) | 3.68947012 |
| 14 | Large for gestational age (HP:0001520) | 3.68685627 |
| 15 | Hyperglycemia (HP:0003074) | 3.68643879 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.53501832 |
| 17 | Hyperammonemia (HP:0001987) | 3.49445804 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.47339854 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.47004429 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.47004429 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.41250357 |
| 22 | Increased serum pyruvate (HP:0003542) | 3.41250357 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.34742262 |
| 24 | Hepatic necrosis (HP:0002605) | 3.29234266 |
| 25 | Exercise-induced myalgia (HP:0003738) | 3.27032710 |
| 26 | Hyperglycinuria (HP:0003108) | 3.26936221 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.25723158 |
| 28 | Ketoacidosis (HP:0001993) | 3.24759243 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.19242120 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18737518 |
| 31 | * Hypolipoproteinemia (HP:0010981) | 3.14783647 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 3.14763525 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.14234434 |
| 34 | Lethargy (HP:0001254) | 3.13673793 |
| 35 | Abnormality of vitamin B metabolism (HP:0004340) | 3.08911260 |
| 36 | Mitochondrial inheritance (HP:0001427) | 3.04376642 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.95405539 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93237909 |
| 39 | * Fat malabsorption (HP:0002630) | 2.92771492 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 2.91497098 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.91497098 |
| 42 | Progressive macrocephaly (HP:0004481) | 2.91066682 |
| 43 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.88302044 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.88215598 |
| 45 | Complement deficiency (HP:0004431) | 2.83682135 |
| 46 | Renal cortical cysts (HP:0000803) | 2.81944361 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.80965669 |
| 48 | Pancreatic cysts (HP:0001737) | 2.80695004 |
| 49 | Hyperventilation (HP:0002883) | 2.74842184 |
| 50 | Increased CSF lactate (HP:0002490) | 2.74825078 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.74820296 |
| 52 | Myoglobinuria (HP:0002913) | 2.74599094 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.74254414 |
| 54 | Metabolic acidosis (HP:0001942) | 2.71044703 |
| 55 | Epidermoid cyst (HP:0200040) | 2.66385319 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.65581674 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.60130073 |
| 58 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.59159689 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.57093717 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.55439623 |
| 61 | Abnormality of urine glucose concentration (HP:0011016) | 2.55417850 |
| 62 | Glycosuria (HP:0003076) | 2.55417850 |
| 63 | Gout (HP:0001997) | 2.53914229 |
| 64 | Hemiparesis (HP:0001269) | 2.52713481 |
| 65 | Fair hair (HP:0002286) | 2.52554176 |
| 66 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.52362718 |
| 67 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.52362718 |
| 68 | Molar tooth sign on MRI (HP:0002419) | 2.52020463 |
| 69 | Abnormality of midbrain morphology (HP:0002418) | 2.52020463 |
| 70 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51678270 |
| 71 | Joint hemorrhage (HP:0005261) | 2.51569931 |
| 72 | Symptomatic seizures (HP:0011145) | 2.51481467 |
| 73 | Medial flaring of the eyebrow (HP:0010747) | 2.51058469 |
| 74 | Lactic acidosis (HP:0003128) | 2.48751289 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.48579354 |
| 76 | Renal Fanconi syndrome (HP:0001994) | 2.48458337 |
| 77 | Abnormality of the intrinsic pathway (HP:0010989) | 2.44651785 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.43798007 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.42645321 |
| 80 | Muscle fiber inclusion bodies (HP:0100299) | 2.41484968 |
| 81 | Late onset (HP:0003584) | 2.40106630 |
| 82 | Methylmalonic acidemia (HP:0002912) | 2.37110015 |
| 83 | Methylmalonic aciduria (HP:0012120) | 2.35455843 |
| 84 | * Vomiting (HP:0002013) | 2.32095222 |
| 85 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.31396222 |
| 86 | Brushfield spots (HP:0001088) | 2.29407630 |
| 87 | Increased muscle lipid content (HP:0009058) | 2.29317481 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.28752654 |
| 89 | Nemaline bodies (HP:0003798) | 2.28568664 |
| 90 | Hamartoma of the eye (HP:0010568) | 2.27487700 |
| 91 | Intestinal atresia (HP:0011100) | 2.26669082 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.25947852 |
| 93 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.25453494 |
| 94 | Exercise-induced muscle cramps (HP:0003710) | 2.24477527 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24044818 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23537626 |
| 97 | Furrowed tongue (HP:0000221) | 2.22284850 |
| 98 | * Steatorrhea (HP:0002570) | 2.21403390 |
| 99 | Hypomagnesemia (HP:0002917) | 2.21223698 |
| 100 | True hermaphroditism (HP:0010459) | 2.21069114 |
| 101 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.19941112 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.19765415 |
| 103 | Cholecystitis (HP:0001082) | 2.19765415 |
| 104 | Tongue fasciculations (HP:0001308) | 2.19723093 |
| 105 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19432178 |
| 106 | CNS demyelination (HP:0007305) | 2.19107198 |
| 107 | Opisthotonus (HP:0002179) | 2.18933726 |
| 108 | Congenital stationary night blindness (HP:0007642) | 2.18550738 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.18472518 |
| 110 | Parakeratosis (HP:0001036) | 2.18324708 |
| 111 | Rhabdomyolysis (HP:0003201) | 2.18131474 |
| 112 | Irritability (HP:0000737) | 2.17155211 |
| 113 | Cholelithiasis (HP:0001081) | 2.16926375 |
| 114 | Conjunctival hamartoma (HP:0100780) | 2.13932228 |
| 115 | Epileptiform EEG discharges (HP:0011182) | 2.13090921 |
| 116 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11417742 |
| 117 | Hypoglycemic seizures (HP:0002173) | 2.11352849 |
| 118 | Hypsarrhythmia (HP:0002521) | 2.11162721 |
| 119 | Generalized hypopigmentation of hair (HP:0011358) | 2.10473595 |
| 120 | Respiratory failure (HP:0002878) | 2.09292948 |
| 121 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04191019 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 2.02030590 |
| 123 | Hydroxyprolinuria (HP:0003080) | 2.02030590 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 2.01640613 |
| 125 | Hypercholesterolemia (HP:0003124) | 2.01339793 |
| 126 | Nephronophthisis (HP:0000090) | 2.00504482 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00096715 |
| 128 | Febrile seizures (HP:0002373) | 2.00057202 |
| 129 | Hypochromic microcytic anemia (HP:0004840) | 1.97957323 |
| 130 | Leukodystrophy (HP:0002415) | 1.97670634 |
| 131 | Proximal tubulopathy (HP:0000114) | 1.96561859 |
| 132 | Increased serum lactate (HP:0002151) | 1.96294424 |
| 133 | Decreased circulating renin level (HP:0003351) | 1.95931182 |
| 134 | Acute hepatic failure (HP:0006554) | 1.95451433 |
| 135 | Exercise intolerance (HP:0003546) | 1.94828261 |
| 136 | Spastic paraparesis (HP:0002313) | 1.94610667 |
| 137 | Hyperphosphaturia (HP:0003109) | 1.94598324 |
| 138 | Vascular calcification (HP:0004934) | 1.94017550 |
| 139 | Chronic hepatic failure (HP:0100626) | 1.93667075 |
| 140 | Abnormal drinking behavior (HP:0030082) | 1.93047741 |
| 141 | Polydipsia (HP:0001959) | 1.93047741 |
| 142 | Muscle stiffness (HP:0003552) | 1.92556270 |
| 143 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91645983 |
| 144 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88569297 |
| 145 | Spontaneous abortion (HP:0005268) | 1.88540518 |
| 146 | Abnormal pancreas size (HP:0012094) | 1.87907176 |
| 147 | Congenital primary aphakia (HP:0007707) | 1.85422609 |
| 148 | Metaphyseal dysplasia (HP:0100255) | 1.84660964 |
| 149 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83570581 |
| 150 | Abnormality of alanine metabolism (HP:0010916) | 1.83570581 |
| 151 | Hyperalaninemia (HP:0003348) | 1.83570581 |
| 152 | Thyroiditis (HP:0100646) | 1.82450913 |
| 153 | Abnormality of the renal medulla (HP:0100957) | 1.82283114 |
| 154 | Gait imbalance (HP:0002141) | 1.81790904 |
| 155 | Muscular hypotonia of the trunk (HP:0008936) | 1.80960742 |
| 156 | Tubular atrophy (HP:0000092) | 1.80850895 |
| 157 | Progressive inability to walk (HP:0002505) | 1.79756540 |
| 158 | Enlarged penis (HP:0000040) | 1.77590940 |
| 159 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.76952149 |
| 160 | Hypoplasia of the fovea (HP:0007750) | 1.76952149 |
| 161 | Muscle fibrillation (HP:0010546) | 1.76606907 |
| 162 | Severe muscular hypotonia (HP:0006829) | 1.75645794 |
| 163 | Delayed gross motor development (HP:0002194) | 1.75184064 |
| 164 | Abnormality of the calf musculature (HP:0001430) | 1.74996295 |
| 165 | Type II lissencephaly (HP:0007260) | 1.74552910 |
| 166 | Neoplasm of the adrenal cortex (HP:0100641) | 1.71342709 |
| 167 | Broad-based gait (HP:0002136) | 1.70716066 |
| 168 | Abnormal biliary tract morphology (HP:0012440) | 1.69814049 |
| 169 | Hypokinesia (HP:0002375) | 1.69684663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.03797949 |
| 2 | OBSCN | 3.26379603 |
| 3 | PINK1 | 3.05005597 |
| 4 | MAPK15 | 2.89477431 |
| 5 | NME1 | 2.85518497 |
| 6 | STK39 | 2.72535902 |
| 7 | PHKG1 | 2.56278989 |
| 8 | PHKG2 | 2.56278989 |
| 9 | ACVR1B | 2.44279928 |
| 10 | INSRR | 2.44021881 |
| 11 | PBK | 2.29862846 |
| 12 | MAP4K2 | 2.29732218 |
| 13 | OXSR1 | 2.27264401 |
| 14 | GRK1 | 2.21268939 |
| 15 | PIK3CG | 2.07237042 |
| 16 | AKT3 | 2.00451859 |
| 17 | PAK3 | 1.88632780 |
| 18 | ERBB4 | 1.86401476 |
| 19 | MAP3K6 | 1.83038102 |
| 20 | MAP3K11 | 1.69497365 |
| 21 | MST4 | 1.65127885 |
| 22 | MAP2K4 | 1.56059650 |
| 23 | MKNK2 | 1.51699794 |
| 24 | STK16 | 1.46274763 |
| 25 | ERBB3 | 1.45445452 |
| 26 | CAMK2G | 1.44137041 |
| 27 | BCR | 1.43958789 |
| 28 | NUAK1 | 1.42958214 |
| 29 | WNK4 | 1.40749192 |
| 30 | ARAF | 1.39338934 |
| 31 | FER | 1.37061336 |
| 32 | MUSK | 1.35271653 |
| 33 | ICK | 1.33103743 |
| 34 | MAP3K4 | 1.29761488 |
| 35 | FGR | 1.27635195 |
| 36 | CASK | 1.26726120 |
| 37 | TRIM28 | 1.26387888 |
| 38 | PIM2 | 1.20046647 |
| 39 | NTRK3 | 1.19937911 |
| 40 | MET | 1.19448094 |
| 41 | CSNK1G3 | 1.17273377 |
| 42 | DAPK2 | 1.15478904 |
| 43 | PLK2 | 1.15003008 |
| 44 | LIMK1 | 1.12444365 |
| 45 | CAMK2B | 1.12407473 |
| 46 | CSNK1G1 | 1.11607625 |
| 47 | TAOK3 | 1.09244209 |
| 48 | ABL2 | 1.06310154 |
| 49 | MAP3K12 | 1.05205356 |
| 50 | ZAK | 1.04796544 |
| 51 | MST1R | 1.04020035 |
| 52 | CAMK2D | 1.03284910 |
| 53 | EPHB1 | 1.01924237 |
| 54 | NLK | 1.01905639 |
| 55 | SIK1 | 1.01569370 |
| 56 | FGFR4 | 1.00240011 |
| 57 | DDR2 | 0.96487640 |
| 58 | FGFR3 | 0.95320326 |
| 59 | PIK3CA | 0.95289709 |
| 60 | STK3 | 0.92787730 |
| 61 | MAPK11 | 0.92375425 |
| 62 | DYRK2 | 0.92029336 |
| 63 | EPHA4 | 0.90945572 |
| 64 | GRK7 | 0.90535504 |
| 65 | PDK4 | 0.90528215 |
| 66 | PDK3 | 0.90528215 |
| 67 | MAPK13 | 0.89912253 |
| 68 | BRAF | 0.89874806 |
| 69 | CAMK2A | 0.88508825 |
| 70 | BRSK2 | 0.88380989 |
| 71 | UHMK1 | 0.88192593 |
| 72 | MYLK | 0.87771716 |
| 73 | PKN1 | 0.86108963 |
| 74 | PNCK | 0.86101393 |
| 75 | NME2 | 0.80410449 |
| 76 | MAP3K2 | 0.79966685 |
| 77 | FRK | 0.79066460 |
| 78 | PDK2 | 0.78062233 |
| 79 | ERN1 | 0.77422947 |
| 80 | MAP3K3 | 0.75672780 |
| 81 | CSNK1G2 | 0.74883747 |
| 82 | PRKCG | 0.74386354 |
| 83 | PRKD3 | 0.74090632 |
| 84 | STK24 | 0.73396591 |
| 85 | MAPK12 | 0.73371783 |
| 86 | STK38L | 0.72390606 |
| 87 | TRPM7 | 0.71237190 |
| 88 | SGK2 | 0.70681584 |
| 89 | DYRK1B | 0.69924914 |
| 90 | TNIK | 0.69383737 |
| 91 | MAPKAPK3 | 0.68844515 |
| 92 | PRKAA2 | 0.67173609 |
| 93 | GSK3A | 0.67036448 |
| 94 | BMPR2 | 0.65216250 |
| 95 | PTK2B | 0.65041590 |
| 96 | CSK | 0.64062994 |
| 97 | CSNK1A1L | 0.63963894 |
| 98 | PLK3 | 0.61044092 |
| 99 | PRKACA | 0.59570070 |
| 100 | EIF2AK3 | 0.59332712 |
| 101 | BMPR1B | 0.57857326 |
| 102 | MAP2K7 | 0.57330244 |
| 103 | PRKCQ | 0.55307634 |
| 104 | WNK3 | 0.54483590 |
| 105 | MAPK4 | 0.53576667 |
| 106 | PRKAA1 | 0.52742210 |
| 107 | CDK19 | 0.51074724 |
| 108 | PRKACG | 0.50977763 |
| 109 | EPHA3 | 0.49509369 |
| 110 | MAPKAPK5 | 0.49036946 |
| 111 | NEK9 | 0.47764884 |
| 112 | PRKCE | 0.47348017 |
| 113 | NEK1 | 0.46775280 |
| 114 | CAMKK2 | 0.45676609 |
| 115 | HIPK2 | 0.45239334 |
| 116 | CSNK1A1 | 0.44795517 |
| 117 | PRKCZ | 0.43987363 |
| 118 | MAP2K3 | 0.43540972 |
| 119 | IRAK1 | 0.42721615 |
| 120 | KDR | 0.41087125 |
| 121 | FGFR2 | 0.41009368 |
| 122 | PRKG1 | 0.40283559 |
| 123 | CAMK1G | 0.40097230 |
| 124 | TLK1 | 0.40034529 |
| 125 | TTN | 0.38659779 |
| 126 | MATK | 0.37503194 |
| 127 | EIF2AK1 | 0.36841164 |
| 128 | ADRBK2 | 0.36295941 |
| 129 | MAP2K6 | 0.35689918 |
| 130 | PRKCI | 0.35049776 |
| 131 | SGK3 | 0.34885172 |
| 132 | SGK223 | 0.34777613 |
| 133 | SGK494 | 0.34777613 |
| 134 | ROCK1 | 0.34380075 |
| 135 | ADRBK1 | 0.34040529 |
| 136 | DAPK1 | 0.33554347 |
| 137 | STK11 | 0.33480707 |
| 138 | TNK2 | 0.32787491 |
| 139 | BUB1 | 0.32578645 |
| 140 | PRKCA | 0.32547927 |
| 141 | PASK | 0.32260555 |
| 142 | TIE1 | 0.32120589 |
| 143 | CSNK2A1 | 0.32064899 |
| 144 | IKBKB | 0.31262014 |
| 145 | TEC | 0.30922103 |
| 146 | MAP2K1 | 0.30450639 |
| 147 | MARK1 | 0.29982496 |
| 148 | CSNK1D | 0.29356894 |
| 149 | SGK1 | 0.27589071 |
| 150 | PRKACB | 0.27363620 |
| 151 | TGFBR1 | 0.25159766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.38815380 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69857623 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.57363491 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50020960 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48252780 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44328087 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.36313607 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32094268 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30972259 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30618313 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29717927 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27867980 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23046063 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17269983 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11694095 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11263423 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.11140474 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10620779 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.09137972 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06520804 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.03055095 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94183063 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89864737 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79240826 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.76841224 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73843910 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73751823 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66900703 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66593260 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.62873612 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.59890286 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59525602 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.58626232 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57918052 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56745677 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56240490 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.54463008 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.50357464 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45958266 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44958647 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44481169 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37971713 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37013505 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36972720 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36647117 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34384515 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33999172 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.28996285 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27826090 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25962407 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22790351 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.19590193 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19133829 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16045543 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15960729 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15883055 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14180659 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12840754 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07736409 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06803220 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03950329 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03192146 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02948039 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00484585 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 1.00176122 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87437001 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87021846 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.83982435 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.83900177 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81878462 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78002451 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76513700 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75692118 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72920355 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72835761 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72819759 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.68656792 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65312118 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65296679 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59175782 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58219222 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53928190 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53180516 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52616428 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51553882 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51466590 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50679613 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50394316 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50001701 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47553949 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46574520 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46545351 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46108653 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43351573 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42980029 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42821138 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.42250960 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41290388 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40690157 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40640695 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38974249 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37400085 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36853513 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36724152 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34969704 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28892615 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23313113 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20944158 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.18107186 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16238406 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14743773 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11599608 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.06501232 |
| 114 | RNA polymerase_Homo sapiens_hsa03020 | 0.04351504 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.03854844 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03329999 |
| 117 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03230051 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.00205868 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0725982 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | -0.0661794 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.0274823 |
| 122 | Lysosome_Homo sapiens_hsa04142 | -0.0207590 |

